Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hepatocyte growth factor activator inhibitor type 1
(
HAI-1
), a Kunitz-type serine protease inhibitor for hepatocyte growth factor activator (HGFA), is responsible for proteolytic activation of hepatocyte growth factor. We examined the expression of HGFA and
HAI-1
in liver tissues of chronic liver diseases including hepatocellular carcinoma (HCC). HGFA expression was detected not only in the liver tissues of chronic hepatitis and
cirrhosis
and in the nontumorous liver tissues surrounding HCC, but also in HCC tissues. On the other hand, none of the liver tissues of hepatitis and
cirrhosis
and none of the nontumorous tissues surrounding HCC were stained with anti-
HAI-1
. However, 35% of HCC tissues were stained with anti-
HAI-1
, and
HAI-1
positivity increased as the histological grade decreased and as serum alpha-fetoprotein increased. Transduction of antisense
HAI-1
inhibited the growth of human hepatoma cells. These results suggest the possibility that
HAI-1
plays an important role in the progression of HCC.
...
PMID:Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma. 1170